Zoledronate, fractures, and mortality after hip fracture.
Karam
Roger
R
Al-Khalidi
Hussein
H
Steinbuch
Michael
M
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D004164:Diphosphonates / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000517:prevention & control*; D006620:Hip Fractures / Q000401:mortality*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D012107:Research Design; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid